Zook to Chair Voltron Board

Tony P. Zook ’82 has been appointed executive chair of the Board of Directors of Voltron Therapeutics, Inc., in New York. He will be instrumental in the further development of the company’s Self-Assembling Vaccine platform and products such as the COVID-19 vaccine, HaloVax and cancer immunotherapy. Zook also serves on the Laidlaw Venture Partners’ Investment and Operations Committee. LVP is the venture capital arm of Laidlaw & Company Ltd., and Voltron is an LVP portfolio company.

He also serves, or has served, on the boards for AltheRx, Inhibikase, Rib-X Pharmaceuticals, the National Pharmaceutical Council, PhRMA and the Pennsylvania Division of the American Cancer Society. He is a member of the FSU Foundation Board of Directors.